The use of amantadine in patients with unresponsive wakefulness syndrome after severe cerebral hemorrhage

@article{Gao2020TheUO,
  title={The use of amantadine in patients with unresponsive wakefulness syndrome after severe cerebral hemorrhage},
  author={Yu Gao and Lin-lin Ma and Fang Liang and Yi Zhang and Lin Yang and Xue-hua Liu and Jing Yang},
  journal={Brain Injury},
  year={2020},
  volume={34},
  pages={1084 - 1088}
}
ABSTRACT Background Amantadine is currently recommended for use in patients of post-traumatic brain injury with unresponsive wakefulness syndrome (UWS). However, the application of amantadine in UWS after cerebral hemorrhage has only been rarely reported. This allows for a further exploration of the role of amantadine in the treatment of UWS resulting from a severe cerebral hemorrhage. Methods We observed the changes of seven patients with UWS of intracerebral hemorrhage after taking amantadine… 
Clinical Decision on Disorders of Consciousness After Acquired Brain Injury: Stepping Forward.
TLDR
A comprehensive review of the progress in clinical identification and management as well as some challenges in the pathophysiology of DOC is presented and a preliminary clinical decision protocol is proposed, which could serve as an ideal reference tool for many medical institutions.
Emerging Treatments for Disorders of Consciousness in Paediatric Age
TLDR
There is a strong call for multicentric, international, and global health initiatives on DoC to devote resources to the paediatric age, as there is now scope for funders to invest in themes specific to DoC affecting the early years of the life course.
Role of the Dopaminergic System in the Striatum and Its Association With Functional Recovery or Rehabilitation After Brain Injury
TLDR
An overview of the functionality of the dopaminergic system in the striatum and its roles in functional recovery or rehabilitation after TBI is provided.
Music Stimulation for People with Disorders of Consciousness: A Scoping Review
TLDR
A scoping review was carried out to identify and provide a synthesis of eligible studies published in English during the 2010–2021 period to assess the impact of music on behavioral and non-behavioral responses of people with disorders of consciousness.
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
TLDR
Considering amantadine’s affinities in vitro and the expected concentration at targets at therapeutic doses in humans, the following primary targets seem to be most plausible: aromatic amino acids decarboxylase, glial-cell derived neurotrophic factor, sigma-1 receptors, phosphodiesterases, and nicotinic receptors.
Behavioral intervention approaches for people with disorders of consciousness: a scoping review.
TLDR
An overall picture of work conducted during the last decade to assess the impact of behavioral intervention strategies on people with disorders of consciousness is provided to provide new insights for improving those strategies and eventually increasing their impact.
Effect of Cinepazide Maleate on Serum Inflammatory Factors of ICU Patients with Severe Cerebral Hemorrhage after Surgery
TLDR
Cinepazide maleate can effectively reduce the serum inflammatory factor levels of ICU patients with severe cerebral hemorrhage after surgery, alleviate the oxidative stress response in the body, and improve the cerebrovascular function and cerebral nerve function, which is worthy of clinical promotion.

References

SHOWING 1-10 OF 18 REFERENCES
Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhage
TLDR
The case of a 36-year-old woman with a subarachnoid haemorrhage caused by a rupture of a right-sided middle cerebral artery aneurysm and subsequent malignant infarction leading to a persistent vegetative state and severe spastic tetraparesis with recurrent myocloni warrants trials to investigate amantadine in the treatment of unresponsive wakefulness syndromes due to acute central nervous system diseases.
Measuring the effect of amantadine in chronic anoxic minimally conscious state
TLDR
The effect of amantadine in a chronic anoxic MCS patient using standardized behavioural evaluations, actigraphy and serial positron emission tomography and the Coma Recovery Scale-Revised (CRS-R) is reported.
Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome
TLDR
The medical community has been unsuccessful in changing the pejorative image associated with the words vegetative state, so it would be better to change the term itself, unresponsive wakefulness syndrome or UWS.
Amantadine to Improve Neurorecovery in Traumatic Brain Injury–Associated Diffuse Axonal Injury: A Pilot Double-blind Randomized Trial
TLDR
There was a consistent trend toward a more rapid functional improvement regardless of when a patient with DAI-associated TBI was started on amantadine in the first 3 months after injury.
Pharmacological and electrical stimulation in chronic disorders of consciousness: New insights and future directions
TLDR
Most of the studies demonstrated considerable improvements with the interventions, but their low strength of evidence limit the generalizability of the findings.
Medical aspects of the persistent vegetative state (1).
This consensus statement of the Multi-Society Task Force summarizes current knowledge of the medical aspects of the persistent vegetative state in adults and children. The vegetative state is a
Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions.
  • R. Clauss
  • Biology, Psychology
    Medical hypotheses
  • 2010
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis
The minimally conscious state: Definition and diagnostic criteria
TLDR
MCS is characterized by inconsistent but clearly discernible behavioral evidence of consciousness and can be distinguished from coma and VS by documenting the presence of specific behavioral features not found in either of these conditions.
Pharmacological treatment of Parkinson disease: a review.
TLDR
Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease, and other therapies for motor and nonmotor features is less well established.
...
...